Menopausal Hot Flashes Market Is Expected to Reach US $5.28 Bn by 2023 & Health Awareness
In the moderately fragmented global market for menopausal hot flashes, the top eight companies accounted for a collective share of more than 50% in 2014, states TMR in a recent report. The top two vendors, Pfizer, Inc. and Novartis AG held a dominant share of nearly 30% of this, commanding a strong hold on the overall development prospects of the market.
View full press release